IPO Year: 2024
Exchange: NASDAQ
Date | Price Target | Rating | Analyst |
---|---|---|---|
6/23/2025 | $37.00 | Buy | TD Cowen |
12/12/2024 | Market Outperform | CJS Securities | |
10/11/2024 | Sector Weight | KeyBanc Capital Markets | |
6/21/2024 | $15.00 | Buy | BTIG Research |
3/6/2024 | $13.00 | Buy | HSBC Securities |
2/27/2024 | $11.50 | Hold → Buy | Deutsche Bank |
2/20/2024 | $15.00 | Buy | Guggenheim |
2/20/2024 | $15.00 | Outperform | Leerink Partners |
2/20/2024 | $15.00 | Buy | UBS |
2/20/2024 | $14.00 | Buy | BofA Securities |
SCHEDULE 13G - BrightSpring Health Services, Inc. (0001865782) (Subject)
8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)
8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)
424B7 - BrightSpring Health Services, Inc. (0001865782) (Filer)
424B7 - BrightSpring Health Services, Inc. (0001865782) (Filer)
S-3ASR - BrightSpring Health Services, Inc. (0001865782) (Filer)
8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)
8-K - BrightSpring Health Services, Inc. (0001865782) (Filer)
SCHEDULE 13G/A - BrightSpring Health Services, Inc. (0001865782) (Subject)
SCHEDULE 13G/A - BrightSpring Health Services, Inc. (0001865782) (Subject)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4/A - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
TD Cowen initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $37.00
CJS Securities initiated coverage of BrightSpring Health Services with a rating of Market Outperform
KeyBanc Capital Markets initiated coverage of BrightSpring Health Services with a rating of Sector Weight
BTIG Research initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $15.00
HSBC Securities initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $13.00
Deutsche Bank upgraded BrightSpring Health Services from Hold to Buy and set a new price target of $11.50
Guggenheim initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $15.00
Leerink Partners initiated coverage of BrightSpring Health Services with a rating of Outperform and set a new price target of $15.00
UBS initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $15.00
BofA Securities initiated coverage of BrightSpring Health Services with a rating of Buy and set a new price target of $14.00
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
3 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
4 - BrightSpring Health Services, Inc. (0001865782) (Issuer)
LOUISVILLE, Ky., July 08, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its second quarter 2025 financial results on Friday, August 1, 2025, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to the conference ca
LOUISVILLE, Ky., June 18, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "BrightSpring Health Services") (NASDAQ:BTSG) is proud to announce that its specialty pharmacy, Onco360®, has been selected as the national pharmacy partner for several newly approved therapies in the treatment of advanced cancers and rare genetic disorders. Onco360® will help provide access, education, data, and expert support for innovative treatments for patients diagnosed with advanced ovarian and lung cancers, as well as neurofibromatosis type 1. "At Onco360®, we continue to partner with innovators and manufacturers to deliver groundbreaking medicines and therapies to patients faci
LOUISVILLE, Ky., June 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ:BTSG) ("BrightSpring" or the "Company"), a leading provider of home and community-based health services for complex populations, today announced the pricing of the previously announced underwritten secondary offering by certain of its stockholders (the "Selling Stockholders"), including affiliates of Kohlberg Kravis Roberts & Co. L.P. (the "KKR Selling Stockholder") and certain members of management, of an aggregate 14,000,000 shares of common stock of BrightSpring pursuant to a shelf registration statement filed by BrightSpring with the U.S. Securities and Exchange Commission (the "SEC"), at the
LOUISVILLE, Ky., June 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (NASDAQ:BTSG) ("BrightSpring" or the "Company"), a leading provider of home and community-based health services for complex populations, today announced that certain of its stockholders (the "Selling Stockholders"), including affiliates of Kohlberg Kravis Roberts & Co. L.P. (the "KKR Selling Stockholder") and certain members of management, intend to offer for sale in an underwritten secondary offering an aggregate 14,000,000 shares of common stock of BrightSpring pursuant to a shelf registration statement filed by BrightSpring with the U.S. Securities and Exchange Commission (the "SEC"). The KKR Selling S
LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the first quarter ended March 31, 2025, and increased Revenue and Adjusted EBITDA1 guidance. Financial Highlights(note: all figures exclude the Community Living business) Net Revenue of $2,878 million, up 25.9% compared to $2,286 million in the first quarter of 2024.Net Income from Continuing Operations of $9.2 million, compared to Net Loss from Continuing Operations of $56.0 million in the first quarter of 2024.Adjusted EBITDA1 of
LOUISVILLE, Ky., April 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its first quarter 2025 financial results on Friday, May 2, 2025, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to the conference call.
LOUISVILLE, Ky., March 06, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the fourth quarter and full year ended December 31, 2024, and increased revenue and Adjusted EBITDA¹ guidance. Financial Highlights Fourth quarter net revenue of $3,053 million, up 28.6% compared to $2,375 million in the fourth quarter of 2023.Fourth quarter net income of $15.4 million, compared to net loss of $7.2 million in the fourth quarter of 2023.Fourth quarter Adjusted EBITDA¹ of $167 million, up 17.4% versus $143 million i
LOUISVILLE, Ky., March 05, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) a leading provider of home and community-based pharmacy and health services for complex populations, today announced the promotion of Jennifer Phipps to Chief Financial Officer. She will succeed Jim Mattingly, current Chief Financial Officer, effective as of March 4, 2025. Ms. Phipps' experience at BrightSpring Health Services spans eight years, and she currently serves as Chief Accounting Officer and Principal Accounting Officer, as well as Chief Financial Officer of BrightSpring's Home Health and Hospice segment and Senior Vice President of Treasury, Ris
LOUISVILLE, Ky., Feb. 06, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its fourth quarter and full year 2024 financial results on Thursday, March 6, 2025, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to th
Streamlined organization and Provider Services segment to optimize resource allocationProvider Services focus on Home Health/Hospice, Personal Care, Rehabilitation Services, and Care Management strategic prioritiesProceeds from the sale will be used to reduce debt resulting in accelerated deleveraging while also increasing capital availabilityDivesture expected to increase Company Revenue and EBITDA Growth Rates and Cash Conversion, as well as Provider Services Revenue and EBITDA Growth Rates and Margin1Company reports 2024 preliminary Revenue and Adjusted EBITDA, above prior guidance issued on November 1, 2024, and initiates 2025 guidance excluding Community Living LOUISVILLE, Ky., Jan.
LOUISVILLE, Ky., Sept. 30, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "the Company") (NASDAQ:BTSG), a leading provider of home- and community-based health services for complex populations, today announced that Dr. Steve Miller was appointed as a Class II member of the Board of Directors. Dr. Miller will also serve as a member of the Board's Audit Committee and as the chair of the Board's Quality & Compliance and Governance Committee. As a nationally recognized advocate for greater access, affordability, and excellence in healthcare, Dr. Miller brings decades of experience to the Company as a medical researcher, clinician, and administrator across numerous hea
LOUISVILLE, Ky., April 26, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced that on April 24, 2024, BrightSpring appointed Timothy A. Wicks as a new member of the Board of Directors. Mr. Wicks will assume his new role effective immediately, bringing the Company's total Board of Directors to seven members, including two independent directors. Mr. Wicks brings over 20 years of executive leadership experience in the healthcare industry to BrightSpring's Board of Directors, including his most recent role as Executive Vice President
LOUISVILLE, Ky., July 08, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its second quarter 2025 financial results on Friday, August 1, 2025, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to the conference ca
LOUISVILLE, Ky., April 10, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its first quarter 2025 financial results on Friday, May 2, 2025, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to the conference call.
LOUISVILLE, Ky., Feb. 06, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its fourth quarter and full year 2024 financial results on Thursday, March 6, 2025, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to th
Streamlined organization and Provider Services segment to optimize resource allocationProvider Services focus on Home Health/Hospice, Personal Care, Rehabilitation Services, and Care Management strategic prioritiesProceeds from the sale will be used to reduce debt resulting in accelerated deleveraging while also increasing capital availabilityDivesture expected to increase Company Revenue and EBITDA Growth Rates and Cash Conversion, as well as Provider Services Revenue and EBITDA Growth Rates and Margin1Company reports 2024 preliminary Revenue and Adjusted EBITDA, above prior guidance issued on November 1, 2024, and initiates 2025 guidance excluding Community Living LOUISVILLE, Ky., Jan.
LOUISVILLE, Ky., Nov. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced financial results for the third quarter ended September 30, 2024, and increases 2024 revenue and Adjusted EBITDA1 guidance. Financial Highlights Net Revenue of $2,907 million, up 28.8% compared to $2,257 million in the third quarter of 2023.Net loss of $9.0 million, compared to net loss of $130.1 million in the third quarter of 2023.Adjusted EBITDA1 of $151 million, up 15.7% versus $131 million in the third quarter of 2023Increased 2024 Revenue and Adju
LOUISVILLE, Ky., Oct. 01, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its third quarter 2024 financial results on Friday, November 1, 2024, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to the conference
LOUISVILLE, Ky., Sept. 03, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services ("BrightSpring" or "the Company") (NASDAQ:BTSG), a leading provider of home and community-based health services for complex populations, today announced that it completed the acquisition of the assets of North Central Florida Hospice, Inc. and Haven Medical Group, LLC (collectively "Haven Hospice"), a Florida-based company holding a Certificate of Need (CON) for comprehensive hospice care services in 18 counties in north central Florida, effective September 1, 2024. "We are excited to welcome Haven Hospice into BrightSpring, expanding our existing hospice services into the CON state of Florida," said Bright
LOUISVILLE, Ky., July 02, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its second quarter 2024 financial results on Friday, August 2, 2024, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to the conference ca
LOUISVILLE, Ky., April 09, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today that it plans to release its first quarter 2024 financial results on Thursday, May 2, 2024, prior to the Company's earnings conference call, which will be held at 8:30 a.m. ET on the same day. To participate in the conference call, please register here before the 8:30 a.m. ET start. A live and archived webcast of the call will be available on the Company's investor relations website at https://ir.brightspringhealth.com under the "Events & Presentations" section, where related presentation materials will be posted prior to the conference cal
LOUISVILLE, Ky., Feb. 29, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ:BTSG) announced today financial results for the fourth quarter and full year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights Net revenue of $2,375 million, up 20.5% compared to $1,971 million in the fourth quarter of 2022 Net revenue growth was negatively impacted by 1.6% due to the Q4 2022 Workforce Solutions divestiture Gross profit of $369 million, or 15.5% of revenue, up 9.2% compared to $338 million, or 17.1% of revenue, in the fourth quarter of 2022 Gross profit growth was negatively impacted by 1.4% due to the Q4 2022 Workforce Solutions
SC 13G - BrightSpring Health Services, Inc. (0001865782) (Subject)
SC 13G - BrightSpring Health Services, Inc. (0001865782) (Subject)
SC 13G - BrightSpring Health Services, Inc. (0001865782) (Subject)
SC 13D - BrightSpring Health Services, Inc. (0001865782) (Subject)